Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681 1682
This examiner grants 61% of resolved cases
Aaron A. Priest is an examiner in Tech Center 1600 and Art Unit 1637. He has managed 808 resolved cases with an allowance rate of 61.3 percent. This 61.3 percent rate indicates that a majority of applications in his docket reach a grant, providing a baseline for applicant expectations.
The interview lift is 25.7 percent. This figure suggests that conducting an interview is a highly effective strategy for increasing the likelihood of a grant. The 25.7 percent lift provides a substantial boost to the allowance rate, making it a critical tactic for practitioners to consider.
The median days to allowance is 1166. This timeline represents the typical duration for applications to reach a final grant. With 808 resolved cases, these metrics offer a clear view of the examiner's performance. The 1166-day median defines the expected prosecution experience for applicants in this docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18227219 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Final Rejection | Natera, Inc. |
| 18227224 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Final Rejection | Natera, Inc. |
| 17781469 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Final Rejection | Oxford Nanopore Technologies PLC |
| 17305239 | WORKFLOW FOR DETECTION OF LIGANDS USING NUCLEIC ACIDS | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17798248 | FIELD DEPLOYABLE CRISPR-CAS DIAGNOSTICS AND METHODS OF USE THEREOF | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18592127 | METHODS FOR DIFFERENTIATING MODIFIED NUCLEOBASES | Non-Final OA | Singular Genomics Systems, Inc. |
| 18356261 | PREDICTION TOOL FOR JUDGING DRUG SENSITIVITY AND LONG-TERM PROGNOSIS OF LIVER CANCER BASED ON GENE DETECTION AND USE THEREOF | Non-Final OA | ZHEJIANG UNIVERSITY |
| 18194590 | MASSIVELY PARALLEL SINGLE CELL ANALYSIS | Final Rejection | Becton, Dickinson and Company |
| 17997696 | QUANTITATIVE BLOCKER DISPLACEMENT AMPLIFICATION (QBDA) SEQUENCING FOR CALIBRATION-FREE AND MULTIPLEXED VARIANT ALLELE FREQUENCY QUANTITATION | Final Rejection | William Marsh Rice University |
| 18235751 | INTEGRATED FUNCTIONAL AND MOLECULAR PROFILING OF CELLS | Final Rejection | University of Houston System |
| 18561853 | MULTIPLEX METHODS OF DETECTING MOLECULES USING NANOPORES | Non-Final OA | Imperial College Innovations Limited |
| 18759437 | Multiplexed Kras Mutation Detection Assay | Final Rejection | Exact Sciences Corporation |
| 18732175 | MULTIPLEX AMPLIFICATION DETECTION ASSAY | Final Rejection | Exact Sciences Corporation |
| 17860577 | ANALYSIS OF MICROBIAL FRAGMENTS IN PLASMA | Non-Final OA | GRAIL, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy